Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ben Haynor
LS
Ben Haynor
Wall Street Analyst
★☆☆☆☆
#2565
on 13Foresight · ranked by our own returns
31%
Success Rate
-17.6%
Average Return
10 of 32 calls profitable · -33.9% vs benchmark
📈 Across the calls we could measure, roughly 31% of Ben Haynor's ratings turned a profit when each position was held for 1 year — averaging -17.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

91 Buy 0 Hold 0 Sell
Ben's Stock Coverage 45 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
SENS
Senseonics Holdings
Jun 08, 2026 BUY Buy
+124.8% avg upside
13 analysts
$12.00
78.11% Upside
·
NUTX
Clinigence Holdings
Jun 02, 2026 BUY Strong Buy
+27.2% avg upside
4 analysts
$235.00
56.11% Upside
·
TSE:PRN
Profound Medical
May 18, 2026 BUY Strong Buy
+96.1% avg upside
11 analysts
$16.97
76.79% Upside
·
PTHS
Pelthos Therapeutics
May 15, 2026 BUY Strong Buy
+95.7% avg upside
8 analysts
$50.00
72.36% Upside
-3.4%
QTI
QT Imaging Holdings
May 14, 2026 BUY Strong Buy
+197.3% avg upside
2 analysts
$10.00
170.21% Upside
·
ELMD
Electromed
May 13, 2026 BUY Strong Buy
-16.4% avg upside
6 analysts
$36.00
7.02% Downside
·
FEMY
Femasys
May 12, 2026 BUY Strong Buy
+1401.7% avg upside
6 analysts
$30.00
642.66% Upside
-46.4%
TMCI
Treace Medical Concepts
May 11, 2026 BUY Hold
+27.0% avg upside
8 analysts
$7.00
67.01% Upside
·
INFU
InfuSystem Holdings
May 08, 2026 BUY Strong Buy
+52.9% avg upside
7 analysts
$17.50
85.86% Upside
+8.7%
OWLT
Owlet
May 08, 2026 BUY Strong Buy
+142.2% avg upside
10 analysts
$14.00
179.94% Upside
-15.8%
SRTS
Sensus Healthcare
May 08, 2026 BUY Strong Buy
+142.0% avg upside
8 analysts
$4.50
61.36% Upside
+10.4%
SRTA
Strata Critical Medical
May 07, 2026 BUY Strong Buy
+20.3% avg upside
11 analysts
$8.00
36.12% Upside
·
ATEC
Alphatec Holdings
May 06, 2026 BUY Strong Buy
+112.9% avg upside
22 analysts
$15.00
70.36% Upside
+15.7%
TCMD
Tactile Systems Technology
May 05, 2026 BUY Strong Buy
+54.0% avg upside
8 analysts
$40.00
50.27% Upside
+7.4%
KIDS
OrthoPediatrics
May 01, 2026 BUY Strong Buy
+59.0% avg upside
10 analysts
$34.00
80.25% Upside
+14.0%
BFLY
Butterfly Network
Apr 30, 2026 BUY Strong Buy
-48.9% avg upside
7 analysts
$5.50
38.27% Downside
+17.9%
PIII
P3 Health Partners
Mar 27, 2026 BUY Buy
+1767.0% avg upside
8 analysts
$4.00
62.89% Downside
+316.0%
CHRN
ChronoScale
Jul 29, 2025 BUY Buy
-59.4% avg upside
4 analysts
$9.50
59.35% Downside
·
LFWD
Lifeward
Jun 03, 2025 BUY Strong Buy
+5.4% avg upside
8 analysts
$3.00
56.57% Downside
-51.5%
MYO
Myomo
Mar 11, 2025 HOLD Strong Buy
+464.7% avg upside
9 analysts
-87.8%
ICCM
Icecure Medical
Mar 20, 2024 BUY Strong Buy
+718.5% avg upside
5 analysts
$2.90
46.25% Downside
+3.3%
DRIO
DarioHealth
Feb 23, 2024 BUY Strong Buy
+22.7% avg upside
5 analysts
$5.50
20.62% Downside
-66.0%
NMTC
NeuroOne Medical Technologies
Feb 14, 2024 BUY Strong Buy
+144.3% avg upside
5 analysts
$3.15
4.25% Downside
+11.1%
AWHL
Aspira Women's Health
Jan 31, 2024 BUY Strong Buy
+1002.0% avg upside
6 analysts
$7.20
1369.30% Upside
-93.0%
PRPO
Precipio
Nov 21, 2023 BUY Buy
-15.3% avg upside
2 analysts
$19.00
15.29% Downside
-15.6%
MOTS
Motus Gi Holdings
Nov 14, 2023 BUY Buy
+49433233.3% avg upside
6 analysts
$8.30
8299899.93% Upside
·
TTOO
T2 Biosystems
Oct 13, 2023 HOLD Buy
+1421150.0% avg upside
10 analysts
$5.35
1069900.09% Upside
·
EVGN
Evogene
Oct 02, 2023 BUY Strong Buy
+1967.8% avg upside
6 analysts
$18.50
3423.09% Upside
-50.8%
NNOX
Nano-X Imaging
Sep 08, 2023 BUY Strong Buy
+473.8% avg upside
7 analysts
$14.50
768.25% Upside
-20.9%
NSPR
InspireMD
Aug 09, 2023 BUY Strong Buy
+447.3% avg upside
8 analysts
$5.20
632.48% Upside
-7.7%
UPHL
UpHealth
Jun 09, 2023 BUY Strong Buy
+2683233.4% avg upside
6 analysts
$4.30
1433233.38% Upside
-70.0%
VSAT
ViaSat
May 26, 2023 BUY Strong Buy
+13.1% avg upside
17 analysts
$81.00
26.27% Upside
-64.6%
BEAT
HeartBeam
May 19, 2023 BUY Buy
+454.2% avg upside
13 analysts
$5.55
630.65% Upside
-5.9%
STKH
Steakholder Foods
Apr 11, 2023 BUY Strong Buy
+2941.0% avg upside
1 analyst
$26.00
2940.99% Upside
-29.3%
CLGN
Collplant Holdings
Feb 17, 2023 BUY Strong Buy
+4905.9% avg upside
3 analysts
$22.75
6648.68% Upside
-53.9%
VIVE
Viveve Medical
Jan 23, 2023 HOLD Buy
+79999900.0% avg upside
8 analysts
·
HIND
Vyome Holdings
Aug 17, 2022 BUY Strong Buy
+1351.6% avg upside
8 analysts
$87.50
3932.32% Upside
-94.4%
CFOR
CapForce
Jul 11, 2022 HOLD Buy
+500.0% avg upside
3 analysts
$12.00
242.92% Upside
·
BACK
Imac Holdings
Aug 19, 2021 HOLD Buy
+12400.0% avg upside
3 analysts
$1.75
4274.93% Upside
·
KPRX
Kiora Pharmaceuticals
May 18, 2021 BUY Strong Buy
+253.8% avg upside
6 analysts
$10.75
324.83% Upside
-90.5%
IBIO
Ibio
Aug 11, 2020 BUY Strong Buy
+244.7% avg upside
11 analysts
$6.65
293.54% Upside
-54.7%
BIOCQ
Biocept
Nov 10, 2016 BUY Strong Buy
+42037400.0% avg upside
7 analysts
$1.55
774899.91% Upside
·
PODD
Insulet
Feb 26, 2016 BUY Strong Buy
+79.0% avg upside
32 analysts
$35.00
76.03% Downside
+44.2%
DXCM
Dexcom
Feb 20, 2014 SELL Strong Buy
+38.6% avg upside
32 analysts
-48.3%
IDXX
Idexx Laboratories
Jan 30, 2014 SELL Buy
+29.2% avg upside
17 analysts
-39.3%
🔒 40 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ben Haynor — Frequently Asked Questions
How accurate are Ben Haynor's stock ratings?
Based on the calls 13Foresight could measure, about 31% of Ben's ratings were profitable over a one-year hold, with an average return of -17.6% per rating, or -33.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ben ranked on 13Foresight?
Ben Haynor is currently ranked #2565 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ben cover?
Ben most recently has ratings on SENS, NUTX, TSE:PRN, PTHS, QTI, ELMD, FEMY, TMCI, INFU, OWLT, SRTS, SRTA and 33 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.